Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
FOLD holding history
Amicus Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FOLD overviewAll 13F holders of FOLDFull Q1 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −223−100.0% | Sold out | Holders |
| Q4 2024 | 223 | $2.10K | <0.1% | +163+271.7% | Added | Holders |
| Q3 2024 | 60 | $641 | <0.1% | +60 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −40−100.0% | Sold out | Holders |
| Q1 2024 | 40 | $471 | <0.1% | −101−71.6% | Reduced | Holders |
| Q4 2023 | 141 | $2.00K | <0.1% | +26+22.6% | Added | Holders |
| Q3 2023 | 115 | $1.40K | <0.1% | −231−66.8% | Reduced | Holders |
| Q2 2023 | 346 | $4.35K | <0.1% | +77+28.6% | Added | Holders |
| Q1 2023 | 269 | $2.98K | <0.1% | −75−21.8% | Reduced | Holders |
| Q4 2022 | 344 | $4.20K | <0.1% | −117−25.4% | Reduced | Holders |
| Q3 2022 | 461 | $5.00K | <0.1% | +339+277.9% | Added | Holders |
| Q2 2022 | 122 | $1.00K | <0.1% | +42+52.5% | Added | Holders |
| Q1 2022 | 80 | $1.00K | <0.1% | +80 | New | Holders |